Epigenomics AG Profile

USD 0.02  0.4%

Epigenomics AG Summary

Epigenomics AG (EPGNF) is traded on OTC Market in USA. It is located in Geneststrasse 5 and employs 43 people. The company currently falls under 'Small-Cap' category with current market capitalization of 120.66 M. Epigenomics AG has 23.16 M outstanding shares. EPIGENOMICS AG BE has accumulated about 15 M in cash with (8.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Epigenomics AG Probability Of Bankruptcy

Epigenomics AG Risk Profiles

Key Fundamentals

Epigenomics AG Against Markets

Current Ratings

Epigenomics AG 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 51% 
Equity ratings for Epigenomics AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Epigenomics AG, a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic tests for the screening, early detection, and diagnosis of cancer in Germany and internationally. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics AG is traded on OTC Market in USA. more
NameEpigenomics AG
CEOGregory HamiltonView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressGeneststrasse 5
ExchangeOTC Market
Contact Number49 30 243 450
CurrencyUSD - US Dollar

Diversify with Epigenomics AG

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Epigenomics AG to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Epigenomics AG Corporate Management
Antje Zeise Manager Investor Relations
Guenther Reiter Member of the Supervisory Board
Ann Kessler Member of the Supervisory Board
Helge Lubenow Member of the Supervisory Board, Ph.D